Pfeiffenberger Brent 4
4 · Century Therapeutics, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-11-19$0.50/sh+35,000$17,329→ 3,271,453 total
Footnotes (2)
- [F1]All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.